TrialJournal of hematology & oncology2024

Memory T-cell enriched haploidentical transplantation with NK cell addback results in promising long-term outcomes: a phase II trial.

Swati Naik et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.